Editas Medicine Inc’s recent filing unveils that its EVP, CHIEF MEDICAL OFFICER Mei Baisong unloaded Company’s shares for reported $1774.0 on Sep 04 ’24. In the deal valued at $3.42 per share,518 shares were sold. As a result of this transaction, Mei Baisong now holds 133,895 shares worth roughly $0.3 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, O’Neill Gilmore Neil sold 1,555 shares, generating $5,325 in total proceeds. Upon selling the shares at $3.42, the CEO now owns 313,724 shares.
Before that, O’Neill Gilmore Neil bought 3,000 shares. Editas Medicine Inc shares valued at $11,760 were divested by the Officer at a price of $3.92 per share.
BofA Securities downgraded its Editas Medicine Inc [EDIT] rating to an Underperform from a a Buy in a research note published on November 25, 2024; the price target was decreased to $1 from $13. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who increased its forecast for the stock in early November from “an In-line” to “an Outperform”. Raymond James also remained covering EDIT and has decreased its forecast on November 04, 2024 with a “Mkt perform” recommendation from previously “an Outperform” rating. BofA Securities revised its rating on August 08, 2024. It rated EDIT as “a Buy” which previously was an “a Neutral”.
Price Performance Review of EDIT
On Friday, Editas Medicine Inc [NASDAQ:EDIT] saw its stock jump 1.82% to $2.24. Over the last five days, the stock has lost -5.49%. Editas Medicine Inc shares have fallen nearly -77.89% since the year began. Nevertheless, the stocks have fallen -78.89% over the past one year. While a 52-week high of $11.69 was reached on 02/28/24, a 52-week low of $2.13 was recorded on 11/26/24. SMA at 50 days reached $3.07, while 200 days put it at $5.08.
Levels Of Support And Resistance For EDIT Stock
The 24-hour chart illustrates a support level at 2.20, which if violated will result in even more drops to 2.17. On the upside, there is a resistance level at 2.28. A further resistance level may holdings at 2.32. The Relative Strength Index (RSI) on the 14-day chart is 30.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.53%. Stochastics %K at 6.32% indicates the stock is a buying.
How much short interest is there in Editas Medicine Inc?
A steep rise in short interest was recorded in Editas Medicine Inc stocks on 2024-11-15, dropping by -2.43 million shares to a total of 15.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 18.33 million shares. There was a decline of -15.26%, which implies that there is a negative sentiment for the stock.
